BSE Live
Nov 13, 16:01Prev. Close
1141.65
Open Price
1142.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 13, 15:57Prev. Close
1139.80
Open Price
1144.90
Bid Price (Qty.)
1126.00 (83)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Jubilant Pharmova (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 15.90 | 15.90 | 15.93 | 15.93 | 15.93 | |
| Total Share Capital | 15.90 | 15.90 | 15.93 | 15.93 | 15.93 | |
| Reserves and Surplus | 2,302.20 | 2,358.60 | 2,398.62 | 1,265.89 | 1,266.52 | |
| Total Reserves and Surplus | 2,302.20 | 2,358.60 | 2,398.62 | 1,265.89 | 1,266.52 | |
| Total Shareholders Funds | 2,318.10 | 2,374.50 | 2,414.55 | 1,281.82 | 1,282.45 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 232.80 | 246.50 | 174.00 | 499.00 | 420.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 8.86 | |
| Other Long Term Liabilities | 20.90 | 28.70 | 35.90 | 5.81 | 7.81 | |
| Long Term Provisions | 27.50 | 26.80 | 22.83 | 5.16 | 5.34 | |
| Total Non-Current Liabilities | 281.20 | 302.00 | 232.73 | 509.97 | 442.00 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 73.30 | 96.40 | 127.50 | 0.00 | 73.00 | |
| Trade Payables | 154.80 | 148.40 | 164.27 | 8.87 | 15.90 | |
| Other Current Liabilities | 73.90 | 63.70 | 58.40 | 20.91 | 23.29 | |
| Short Term Provisions | 8.30 | 6.90 | 11.02 | 7.90 | 7.97 | |
| Total Current Liabilities | 310.30 | 315.40 | 361.19 | 37.68 | 120.15 | |
| Total Capital And Liabilities | 2,909.60 | 2,991.90 | 3,008.47 | 1,829.47 | 1,844.60 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 556.20 | 572.40 | 549.51 | 123.54 | 127.08 | |
| Intangible Assets | 142.50 | 138.90 | 137.89 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 19.30 | 37.00 | 46.97 | 0.06 | 0.33 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 718.00 | 748.30 | 734.37 | 123.60 | 127.41 | |
| Non-Current Investments | 1,657.00 | 1,656.90 | 1,656.57 | 1,645.75 | 1,645.98 | |
| Deferred Tax Assets [Net] | 11.60 | 11.90 | 17.03 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.20 | 0.20 | 0.30 | 0.06 | 1.73 | |
| Other Non-Current Assets | 38.60 | 34.00 | 21.33 | 12.16 | 3.23 | |
| Total Non-Current Assets | 2,425.40 | 2,451.30 | 2,429.59 | 1,781.57 | 1,778.35 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 232.40 | 250.90 | 313.60 | 0.00 | 0.00 | |
| Trade Receivables | 206.30 | 194.20 | 188.52 | 21.23 | 0.00 | |
| Cash And Cash Equivalents | 12.60 | 36.10 | 10.99 | 22.51 | 40.33 | |
| Short Term Loans And Advances | 0.20 | 0.10 | 0.02 | 0.00 | 0.00 | |
| OtherCurrentAssets | 32.70 | 59.30 | 65.74 | 4.16 | 25.92 | |
| Total Current Assets | 484.20 | 540.60 | 578.88 | 47.90 | 66.25 | |
| Total Assets | 2,909.60 | 2,991.90 | 3,008.47 | 1,829.47 | 1,844.60 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 75.70 | 92.00 | 116.26 | 69.70 | 70.39 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 180.90 | 212.40 | 256.41 | 0.30 | 911.70 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 568.90 | 730.69 | 709.97 | 158.00 | 1,120.70 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 1,657.00 | 1,656.90 | 1,656.57 | 1,645.75 | 1,645.98 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
10.11.2025
Jubilant Pharmo Standalone September 2025 Net Sales at Rs 66.40 crore, down 59.93% Y-o-Y
31.10.2025
Jubilant Pharmo Consolidated September 2025 Net Sales at Rs 1,966.40 crore, up 12.22% Y-o-Y
30.07.2025
Jubilant Pharmo Consolidated June 2025 Net Sales at Rs 1,900.70 crore, up 9.76% Y-o-Y
30.07.2025
Jubilant Pharmo Standalone June 2025 Net Sales at Rs 59.50 crore, down 64.31% Y-o-Y
10.11.2025
Jubilant Pharmo Standalone September 2025 Net Sales at Rs 66.40 crore, down 59.93% Y-o-Y
31.10.2025
Jubilant Pharmo Consolidated September 2025 Net Sales at Rs 1,966.40 crore, up 12.22% Y-o-Y
30.07.2025
Jubilant Pharmo Consolidated June 2025 Net Sales at Rs 1,900.70 crore, up 9.76% Y-o-Y
30.07.2025
Jubilant Pharmo Standalone June 2025 Net Sales at Rs 59.50 crore, down 64.31% Y-o-Y
18.01.2021
Jubilant Life Sciences Q3 PAT seen up 14.9% YoY to Rs. 238 cr: Prabhudas Lilladher
12.07.2019
Jubilant Life Sciences Q1 PAT may dip 10.4% YoY to Rs. 181.4 cr: Prabhudas Lilladher
12.04.2019
Jubilant Life Sciences Q4 PAT seen up 36.3% YoY to Rs. 211.2 cr: Prabhudas Lilladher
11.01.2019
Jubilant Life Science Q3 PAT seen up 13.8% YoY to Rs. 241.8 cr: ICICI Direct